BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38727300)

  • 1. Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis.
    Yang B; Qiao Y; Yan D; Meng Q
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage and fibroblast trajectory inference and crosstalk analysis during myocardial infarction using integrated single-cell transcriptomic datasets.
    Ke D; Cao M; Ni J; Yuan Y; Deng J; Chen S; Dai X; Zhou H
    J Transl Med; 2024 Jun; 22(1):560. PubMed ID: 38867219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis After Reperfusion Injury.
    Yue Y; Huang S; Wang L; Wu Z; Liang M; Li H; Lv L; Li W; Wu Z
    Circ J; 2020 Mar; 84(4):626-635. PubMed ID: 32161201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Fibrosis and Fibroblasts.
    Kurose H
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis.
    MacKenna D; Summerour SR; Villarreal FJ
    Cardiovasc Res; 2000 May; 46(2):257-63. PubMed ID: 10773229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.
    Trial J; Heredia CP; Taffet GE; Entman ML; Cieslik KA
    Basic Res Cardiol; 2017 Jul; 112(4):34. PubMed ID: 28478479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative cross talk between cardiac cells and macrophages.
    Whitehead AJ; Engler AJ
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2211-H2221. PubMed ID: 33769920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins of cardiac fibroblasts.
    Moore-Morris T; Cattaneo P; Puceat M; Evans SM
    J Mol Cell Cardiol; 2016 Feb; 91():1-5. PubMed ID: 26748307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix-mediated cellular communication in the heart.
    Valiente-Alandi I; Schafer AE; Blaxall BC
    J Mol Cell Cardiol; 2016 Feb; 91():228-37. PubMed ID: 26778458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac fibroblasts: from development to heart failure.
    Moore-Morris T; Guimarães-Camboa N; Yutzey KE; Pucéat M; Evans SM
    J Mol Med (Berl); 2015 Aug; 93(8):823-30. PubMed ID: 26169532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.
    Westermann D; Lindner D; Kasner M; Zietsch C; Savvatis K; Escher F; von Schlippenbach J; Skurk C; Steendijk P; Riad A; Poller W; Schultheiss HP; Tschöpe C
    Circ Heart Fail; 2011 Jan; 4(1):44-52. PubMed ID: 21075869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
    Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
    Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A primer on current progress in cardiac fibrosis.
    Al Hattab D; Czubryt MP
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1091-1099. PubMed ID: 28273426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for the role of macrophages in a model of myocardial fibrosis: CCR2(-/-) mice exhibit an M2 phenotypic shift in resident cardiac macrophages.
    Falkenham A; Myers T; Wong C; Legare JF
    Cardiovasc Pathol; 2016; 25(5):390-8. PubMed ID: 27327107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome.
    Liu W; Zhang X; Zhao M; Zhang X; Chi J; Liu Y; Lin F; Fu Y; Ma D; Yin X
    Cell Physiol Biochem; 2015; 35(6):2483-500. PubMed ID: 25967877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.